BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 12907944)

  • 1. Hypoxia-inducible VEGF gene delivery to ischemic myocardium using water-soluble lipopolymer.
    Lee M; Rentz J; Bikram M; Han S; Bull DA; Kim SW
    Gene Ther; 2003 Sep; 10(18):1535-42. PubMed ID: 12907944
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypoxia-inducible gene expression system using the erythropoietin enhancer and 3'-untranslated region for the VEGF gene therapy.
    Lee M; Choi D; Choi MJ; Jeong JH; Kim WJ; Oh S; Kim YH; Bull DA; Kim SW
    J Control Release; 2006 Sep; 115(1):113-9. PubMed ID: 16962197
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Augmentation of erythropoietin enhancer-mediated hypoxia-inducible gene expression by co-transfection of a plasmid encoding hypoxia-inducible factor 1alpha for ischemic tissue targeting gene therapy.
    Lee S; Kim K; Kim HA; Kim SW; Lee M
    J Drug Target; 2008 Jan; 16(1):43-50. PubMed ID: 18172819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Gene therapy of neural cell injuries in vitro using the hypoxia-inducible GM-CSF expression plasmids and water-soluble lipopolymer (WSLP).
    Kim JM; Lee M; Kim KH; Ha Y; Choi JK; Park SR; Park H; Park HC; Ahn CH; Kim SW; Choi BH
    J Control Release; 2009 Jan; 133(1):60-7. PubMed ID: 18938203
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypoxia-inducible expression of vascular endothelial growth factor for the treatment of spinal cord injury in a rat model.
    Choi UH; Ha Y; Huang X; Park SR; Chung J; Hyun DK; Park H; Park HC; Kim SW; Lee M
    J Neurosurg Spine; 2007 Jul; 7(1):54-60. PubMed ID: 17633488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hypoxia-inducible vascular endothelial growth factor gene therapy using the oxygen-dependent degradation domain in myocardial ischemia.
    Kim HA; Lim S; Moon HH; Kim SW; Hwang KC; Lee M; Kim SH; Choi D
    Pharm Res; 2010 Oct; 27(10):2075-84. PubMed ID: 20607367
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adeno-associated viral vector-mediated hypoxia response element-regulated gene expression in mouse ischemic heart model.
    Su H; Arakawa-Hoyt J; Kan YW
    Proc Natl Acad Sci U S A; 2002 Jul; 99(14):9480-5. PubMed ID: 12084814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Polymeric gene delivery of ischemia-inducible VEGF significantly attenuates infarct size and apoptosis following myocardial infarct.
    Yockman JW; Choi D; Whitten MG; Chang CW; Kastenmeier A; Erickson H; Albanil A; Lee M; Kim SW; Bull DA
    Gene Ther; 2009 Jan; 16(1):127-35. PubMed ID: 18784748
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delivery of Hypoxia-Inducible Heme Oxygenase-1 Gene for Site-Specific Gene Therapy in the Ischemic Stroke Animal Model.
    Choi M; Oh J; Rhim T; Lee M
    Pharm Res; 2016 Sep; 33(9):2250-8. PubMed ID: 27324961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of the oxygen-dependent degradation domain in a hypoxia-inducible gene expression system in vascular endothelial growth factor gene therapy.
    Jin H; Liu ML; Kim HA; Lee M; An S; Oh J; Cho J; Yi S; Kim K; Yoon D; Ha Y
    Spine (Phila Pa 1976); 2009 Dec; 34(26):E952-8. PubMed ID: 20010384
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibitory mechanism of vascular endothelial growth factor (VEGF) by bucillamine.
    Koyama S; Takagi H; Otani A; Oh H; Nishimura K; Honda Y
    Br J Pharmacol; 2002 Nov; 137(6):901-9. PubMed ID: 12411422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhancement of gene expression under hypoxic conditions using fragments of the human vascular endothelial growth factor and the erythropoietin genes.
    Shibata T; Akiyama N; Noda M; Sasai K; Hiraoka M
    Int J Radiat Oncol Biol Phys; 1998 Nov; 42(4):913-6. PubMed ID: 9845121
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene therapy with an erythropoietin enhancer-mediated, hypoxia-inducible gene expression system in the corpus cavernosum of mice with high-cholesterol diet-induced erectile dysfunction.
    Ryu JK; Lee M; Choi MJ; Kim HA; Jin HR; Kim WJ; Yin GN; Song KM; Kwon MH; Suh JK
    J Androl; 2012; 33(5):845-53. PubMed ID: 22403284
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel polymer carriers and gene constructs for treatment of myocardial ischemia and infarction.
    Yockman JW; Kastenmeier A; Erickson HM; Brumbach JG; Whitten MG; Albanil A; Li DY; Kim SW; Bull DA
    J Control Release; 2008 Dec; 132(3):260-6. PubMed ID: 18662730
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A hypoxia-inducible gene expression system using erythropoietin 3' untranslated region for the gene therapy of rat spinal cord injury.
    Choi BH; Ha Y; Ahn CH; Huang X; Kim JM; Park SR; Park H; Park HC; Kim SW; Lee M
    Neurosci Lett; 2007 Jan; 412(2):118-22. PubMed ID: 17178192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transmyocardial laser revascularization combined with vascular endothelial growth factor 121 (VEGF121) gene therapy for chronic myocardial ischemia--do the effects really add up?
    Heilmann CA; Attmann T; von Samson P; Göbel H; Marmé D; Beyersdorf F; Lutter G
    Eur J Cardiothorac Surg; 2003 Jan; 23(1):74-80. PubMed ID: 12493508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Complete reversal of ischemic wall motion abnormalities by combined use of gene therapy with transmyocardial laser revascularization.
    Sayeed-Shah U; Mann MJ; Martin J; Grachev S; Reimold S; Laurence R; Dzau V; Cohn LH
    J Thorac Cardiovasc Surg; 1998 Nov; 116(5):763-9. PubMed ID: 9806383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled nonviral gene delivery and expression using stable neural stem cell line transfected with a hypoxia-inducible gene expression system.
    Liu ML; Oh JS; An SS; Pennant WA; Kim HJ; Gwak SJ; Yoon DH; Kim KN; Lee M; Ha Y
    J Gene Med; 2010 Dec; 12(12):990-1001. PubMed ID: 21157823
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic angiogenesis using genetic transfection. An in vitro quantitative and functional study after gene code transfer for vascular endothelial growth factor].
    Zaric V; Weltin D; Stephan D
    Arch Mal Coeur Vaiss; 2000 Aug; 93(8):987-91. PubMed ID: 10989743
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intramyocardial gene therapy with naked DNA encoding vascular endothelial growth factor improves collateral flow to ischemic myocardium.
    Tio RA; Tkebuchava T; Scheuermann TH; Lebherz C; Magner M; Kearny M; Esakof DD; Isner JM; Symes JF
    Hum Gene Ther; 1999 Dec; 10(18):2953-60. PubMed ID: 10609656
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.